Answers are grounded in this paper and cite their sources.
Our calculated prevalence is twice as high as previously reported and reinforces the need for enhanced sickle cell diagnostic services. Our district-level data will inform public health policy, allowing screening and disease-modifying hydroxyurea therapy to be focused on high-prevalence areas, until universal newborn screening is available.
No takes yet. Share an insight, caveat, or question.
Ambrose et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: